Compare CELH & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CELH | RVTY |
|---|---|---|
| Founded | 2004 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 11.8B |
| IPO Year | 2008 | 1994 |
| Metric | CELH | RVTY |
|---|---|---|
| Price | $41.42 | $85.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 15 |
| Target Price | $66.50 | ★ $113.00 |
| AVG Volume (30 Days) | ★ 5.4M | 1.0M |
| Earning Date | 05-05-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 0.33% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.25 | ★ 2.07 |
| Revenue | $1,318,014,000.00 | ★ $3,311,822,000.00 |
| Revenue This Year | $37.68 | $6.34 |
| Revenue Next Year | $10.02 | $5.10 |
| P/E Ratio | $171.18 | ★ $41.47 |
| Revenue Growth | ★ 101.65 | N/A |
| 52 Week Low | $32.36 | $81.36 |
| 52 Week High | $66.74 | $118.30 |
| Indicator | CELH | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 38.50 | 33.32 |
| Support Level | $41.56 | $83.11 |
| Resistance Level | $47.24 | $94.75 |
| Average True Range (ATR) | 2.03 | 3.02 |
| MACD | -0.32 | -0.39 |
| Stochastic Oscillator | 9.99 | 14.14 |
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. The firm now owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It dedicates its efforts to product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.